Bharat Biotech

Bharat Biotech Terminates MoU With Brazilian Partners After Controversy Over Covaxin Deal

Centre Revises Rates For Procuring Covishield & Covaxin, Places Order To Get 66 Crore Doses: Report

Coronavirus HIGHLIGHTS: Process Of Covaxin's Emergency Use Approval By WHO Begins, Reveals Bharat Biotech

Covaxin Closer To WHO Approval? Covid-19 Vaccine Trial Data 'Looks Good', Says Chief Scientist

Coronavirus HIGHLIGHTS: Over 2 Crore 'Unutilised' COVID-19 Vaccine Doses Still Available With States, Says Govt

Coronavirus HIGHLIGHTS: Goa Govt Allows Bars, Restaurants To Function With 50% Seating Capacity

Coronavirus HIGHLIGHTS: Delhi Reports 86 New Covid Cases, 5 Deaths In Last 24 Hours

'Covaxin Found To Be 77.8% Effective In Final Analysis Of Phase III Trials', Claims Bharat Biotech

Coronavirus HIGHLIGHTS: Zydus Cadila Application For Zycov Jab Under Evaluation, Says Niti Aayog

Coronavirus HIGHLIGHTS: Confident Of Getting EMA's Approval In A month For Covishield, Says SII Chief Adar Poonawalla

Covaxin Effectively Neutralises Covid-19's Alpha & Delta Variant: US Health Research Institute

'Pricing Clearly Established For Supplies Outside India': Bharat Biotech On Brazil Covaxin Deal Controversy